keyword
https://read.qxmd.com/read/38642258/comprehensive-pan-cancer-analysis-reveals-prognostic-implications-of-tmem92-in-the-tumor-immune-microenvironment
#1
JOURNAL ARTICLE
Zheng Wu, Teng Pan, Wen Li, Yue-Hua Zhang, Sheng-Hu Guo, Ya Liu, Lei Zhang, Zhi-Yu Wang
BACKGROUND: Transmembrane protein 92 (TMEM92) has been implicated in the facilitation of tumor progression. Nevertheless, comprehensive analyses concerning the prognostic significance of TMEM92, as well as its role in immunological responses across diverse cancer types, remain to be elucidated. METHODS: In this study, data was sourced from a range of publicly accessible online platforms and databases, including TCGA, GTEx, UCSC Xena, CCLE, cBioPortal, HPA, TIMER2...
April 20, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38639631/identification-of-the-immune-related-lncrna-snhg14-mir-200a-3p-pcolce2-axis-in-colorectal-cancer
#2
JOURNAL ARTICLE
Na Li, Jiangli Shen, Ximin Qiao, Qiang Liu, Xiaoqiang Dai, Xiongwen Jiao
CONTEXT: Procollagen C-endopeptidase enhancer 2 (PCOLCE2) is associated with the degradation of the extracellular matrix and collagen-chain trimerization, playing a yet unexplored role in tumor prognosis. OBJECTIVE: The study intended to characterize PCOLCE2's influence on colorectal cancer (CRC) using expression analysis and to investigate its prognostic potential. DESIGN: The research team performed a genetic analysis using genetic databases, including The Cancer Genome Atlas (TCGA), Gene Expression Profiling Interactive Analysis (GEPIA), the Tumor IMmune Estimation Resource (TIMER), and LinkedOmics...
April 18, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38633426/a-method-to-comprehensively-identify-germline-snvs-indels-and-cnvs-from-whole-exome-sequencing-data-of-brca1-2-negative-breast-cancer-patients
#3
JOURNAL ARTICLE
Andrea Bianchi, Veronica Zelli, Andrea D'Angelo, Alessandro Di Matteo, Giulia Scoccia, Katia Cannita, Antigone S Dimas, Stavros Glentis, Francesca Zazzeroni, Edoardo Alesse, Antinisca Di Marco, Alessandra Tessitore
In the rapidly evolving field of genomics, understanding the genetic basis of complex diseases like breast cancer, particularly its familial/hereditary forms, is crucial. Current methods often examine genomic variants-such as Single Nucleotide Variants (SNVs), insertions/deletions (Indels), and Copy Number Variations (CNVs)-separately, lacking an integrated approach. Here, we introduced a robust, flexible methodology for a comprehensive variants' analysis using Whole Exome Sequencing (WES) data. Our approach uniquely combines meticulous validation with an effective variant filtering strategy...
June 2024: NAR genomics and bioinformatics
https://read.qxmd.com/read/38633247/coupled-scrna-seq-and-bulk-seq-reveal-the-role-of-hmmr-in-hepatocellular-carcinoma
#4
JOURNAL ARTICLE
Zhixiong Su, Yufang He, Lijie You, Guifeng Zhang, Jingbo Chen, Zhenhua Liu
BACKGROUND: Hyaluronan-mediated motility receptor (HMMR) is overexpressed in multiple carcinomas and influences the development and treatment of several cancers. However, its role in hepatocellular carcinoma (HCC) remains unclear. METHODS: The "limma" and "GSVA" packages in R were used to perform differential expression analysis and to assess the activity of signalling pathways, respectively. InferCNV was used to infer copy number variation (CNV) for each hepatocyte and "CellChat" was used to analyse intercellular communication networks...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38630441/host-nuclear-genome-copy-number-variations-identify-high-risk-anal-precancers-in-people-living-with-hiv
#5
JOURNAL ARTICLE
Tinaye Mutetwa, Yuxin Liu, Richard Silvera, Michelle Evans, Michael Yurich, Joseph Tripodi, Issa Leonard, Jane Houldsworth, Zeynep Gümüş, Anne M Bowcock, Keith Sigel, Michael Gaisa, Paz Polak
BACKGROUND: People living with HIV (PLWH) have substantially increased incidence of anal precancer and cancer. There are very little data regarding genomic disturbances in anal precancers among PLWH. Here, we identified specific chromosomal variants in anal squamous intraepithelial lesions. METHODS: We collected 63 anal biopsy specimens (27 low-grade intraepithelial lesions [LSIL] and 36 high-grade intraepithelial lesions [HSIL]) from PLWH obtained as part of anal cancer screening in our NYC-based health system...
April 15, 2024: Journal of Acquired Immune Deficiency Syndromes: JAIDS
https://read.qxmd.com/read/38628662/prevalence-and-associations-of-co-occurrence-of-nfe2l2-mutations-and-chromosome-3q26-amplification-in-lung-cancer
#6
JOURNAL ARTICLE
Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zhang
Background   NFE2L2 (nuclear factor erythroid-2-related factor-2) encodes a basic leucine zipper (bZIP) transcription factor and exhibits variations in various tumor types, including lung cancer. In this study, we comprehensively investigated the impact of simultaneous mutations on the survival of NFE2L2 -mutant lung cancer patients within specific subgroups. Methods  A cohort of 1,103 lung cancer patients was analyzed using hybridization capture-based next-generation sequencing. Results  The NFE2L2 gene had alterations in 3...
June 2024: Global medical genetics
https://read.qxmd.com/read/38615479/endometrial-carcinoma-10%C3%A2-years-of-tcga-the-cancer-genome-atlas-a-critical-reappraisal-with-comments-on-figo-2023-staging
#7
REVIEW
Iñigo Espinosa, Emanuela D'Angelo, Jaime Prat
The Cancer Genome Atlas (TCGA) Research Network described 4 molecular subgroups of endometrial carcinomas with different outcome: 1) POLE ultramutated endometrioid carcinomas which have an indolent behavior; 2) microsatellite instability hypermutated endometrioid carcinomas associated with intermediate prognosis; 3) copy-number low endometrioid carcinomas also with intermediate prognosis; and 4) copy-number high predominantly serous (non-endometrioid) but also serous-like endometrioid carcinomas, almost always carrying TP53 mutations, with poor clinical outcome...
April 13, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38612473/multiomics-based-feature-extraction-and-selection-for-the-prediction-of-lung-cancer-survival
#8
JOURNAL ARTICLE
Roman Jaksik, Kamila Szumała, Khanh Ngoc Dinh, Jarosław Śmieja
Lung cancer is a global health challenge, hindered by delayed diagnosis and the disease's complex molecular landscape. Accurate patient survival prediction is critical, motivating the exploration of various -omics datasets using machine learning methods. Leveraging multi-omics data, this study seeks to enhance the accuracy of survival prediction by proposing new feature extraction techniques combined with unbiased feature selection. Two lung adenocarcinoma multi-omics datasets, originating from the TCGA and CPTAC-3 projects, were employed for this purpose, emphasizing gene expression, methylation, and mutations as the most relevant data sources that provide features for the survival prediction models...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38601163/computational-identification-and-experimental-verification-of-a-novel-signature-based-on-sars-cov-2-related-genes-for-predicting-prognosis-immune-microenvironment-and-therapeutic-strategies-in-lung-adenocarcinoma-patients
#9
JOURNAL ARTICLE
Yuzhi Wang, Yunfei Xu, Yuqin Deng, Liqiong Yang, Dengchao Wang, Zhizhen Yang, Yi Zhang
BACKGROUND: Early research indicates that cancer patients are more vulnerable to adverse outcomes and mortality when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nonetheless, the specific attributes of SARS-CoV-2 in lung Adenocarcinoma (LUAD) have not been extensively and methodically examined. METHODS: We acquired 322 SARS-CoV-2 infection-related genes (CRGs) from the Human Protein Atlas database. Using an integrative machine learning approach with 10 algorithms, we developed a SARS-CoV-2 score (Cov-2S) signature across The Cancer Genome Atlas and datasets GSE72094, GSE68465, and GSE31210...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38590909/pan-cancer-analyses-reveal-genomics-and-clinical-outcome-association-of-the-fatty-acid-oxidation-regulators-in-cancer
#10
JOURNAL ARTICLE
Fu-Bin Zhang, Lei Gan, Tian-Hong Zhu, Hui-Qing Ding, Cheng-Hao Wu, Yu-Tao Guan, Xue-Qin Chen
BACKGROUND: Fatty acid oxidation (FAO) is considered to play a vital part in tumor metabolic reprogramming. But the comprehensive description of FAO dysregulation in tumors has not been unknown. METHODS: We obtained FAO genes, RNA-seq data and clinical information from the Msigdb, TCGA and GTEx databases. We assessed their prognosis value using univariate cox analysis, survival analysis and Kaplan-Meier curve. We determined the function of FAO genes using gene set variation analysis...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38590858/integrated-analysis-of-scrna-seq-and-bulk-rna-seq-identifies-fbxo2-as-a-candidate-biomarker-associated-with-chemoresistance-in-hgsoc
#11
JOURNAL ARTICLE
Wenwen Lai, Ruixiang Xie, Chen Chen, Weiming Lou, Haiyan Yang, Libin Deng, Quqin Lu, Xiaoli Tang
BACKGROUND: High-grade serous ovarian carcinoma (HGSOC) is the most prevalent and aggressive histological subtype of epithelial ovarian cancer. Around 80% of individuals will experience a recurrence within five years because of resistance to chemotherapy, despite initially responding well to platinum-based treatment. Biomarkers associated with chemoresistance are desperately needed in clinical practice. METHODS: We jointly analyzed the transcriptomic profiles of single-cell and bulk datasets of HGSOC to identify cell types associated with chemoresistance...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38584220/an-original-aneuploidy-related-gene-model-for-predicting-lung-adenocarcinoma-survival-and-guiding-therapy
#12
JOURNAL ARTICLE
Yalei Zhang, Dongmei Li
Aneuploidy is a hallmark of cancers, but the role of aneuploidy-related genes in lung adenocarcinoma (LUAD) and their prognostic value remain elusive. Gene expression and copy number variation (CNV) data were enrolled from TCGA and GEO database. Consistency clustering analysis was performed for molecular cluster. Tumor microenvironment was assessed by the xCell and ESTIMATE algorithm. Limma package was used for selecting differentially expressed genes (DEGs). LASSO and stepwise multivariate Cox regression analysis were used to establish an aneuploidy-related riskscore (ARS) signature...
April 7, 2024: Scientific Reports
https://read.qxmd.com/read/38576569/differential-whole-genome-doubling-based-signatures-for-improvement-on-clinical-outcomes-and-drug-response-in-patients-with-breast-cancer
#13
JOURNAL ARTICLE
Yingli Lv, Guotao Feng, Lei Yang, Xiaoliang Wu, Chengyi Wang, Aokun Ye, Shuyuan Wang, Chaohan Xu, Hongbo Shi
Whole genome doublings (WGD), a hallmark of human cancer, is pervasive in breast cancer patients. However, the molecular mechanism of the complete impact of WGD on survival and treatment response in breast cancer remains unclear. To address this, we performed a comprehensive and systematic analysis of WGD, aiming to identify distinct genetic alterations linked to WGD and highlight its improvement on clinical outcomes and treatment response for breast cancer. A linear regression model along with weighted gene co-expression network analysis (WGCNA) was applied on The Cancer Genome Atlas (TCGA) dataset to identify critical genes related to WGD...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38572916/identification-and-validation-of-a-novel-anoikis-related-prognostic-model-for-prostate-cancer
#14
JOURNAL ARTICLE
Peipei Zhang, Wenzhi Lv, Yang Luan, Wei Cai, Xiangde Min, Zhaoyan Feng
BACKGROUND: Anoikis resistance is a hallmark characteristic of oncogenic transformation, which is crucial for tumor progression and metastasis. The aim of this study was to identify and validate a novel anoikis-related prognostic model for prostate cancer (PCa). METHODS: We collected a gene expression profile, single nucleotide polymorphism mutation and copy number variation (CNV) data of 495 PCa patients from the TCGA database and 140 PCa samples from the MSKCC dataset...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38560150/the-prognostic-values-and-immune-characteristics-of-polo-like-kinases-plks-family-a-pan-cancer-multi-omics-analysis
#15
JOURNAL ARTICLE
Chong Shen, Tong Wang, Kai Li, Chong Fu, Shaobo Yang, Zhe Zhang, Zhouliang Wu, Zhi Li, Zhuolun Li, Yuda Lin, Yu Zhang, Jian Guo, Zhenqian Fan, Hailong Hu
BACKGROUND: In the realm of tumor-targeted therapeutics, Polo-like kinases (PLKs) are a significant group of protein kinases that were found recently as being related to tumors. However, the significance of PLKs in pan-cancer remains systematically studied. METHODS AND MATERIALS: We integrated multi-omics data to comprehensively investigate the expression patterns of the PLK family across various cancer types. Subsequently, study examined the associations between tumor mutation burden (TMB), microsatellite instability (MSI), immune subtype classification, immune infiltration, tumor microenvironment scores, immune checkpoint gene expression, and the PLKs expression profiles within various tumor types...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38559183/tumor-cell-based-liquid-biopsy-using-high-throughput-microfluidic-enrichment-of-entire-leukapheresis-product
#16
Avanish Mishra, Shih-Bo Huang, Taronish Dubash, Risa Burr, Jon F Edd, Ben S Wittner, Quinn E Cunneely, Victor R Putaturo, Akansha Deshpande, Ezgi Antmen, Kaustav A Gopinathan, Keisuke Otani, Yoshiyuki Miyazawa, Ji Eun Kwak, Sara Y Guay, Justin Kelly, John Walsh, Linda Nieman, Isabella Galler, PuiYee Chan, Michael S Lawrence, Ryan J Sullivan, Aditya Bardia, Douglas S Micalizzi, Lecia V Sequist, Richard J Lee, Joseph W Franses, David T Ting, Patricia A R Brunker, Shyamala Maheswaran, David T Miyamoto, Daniel A Haber, Mehmet Toner
Circulating Tumor Cells (CTCs), interrogated by sampling blood from patients with cancer, contain multiple analytes, including intact RNA, high molecular weight DNA, proteins, and metabolic markers. However, the clinical utility of tumor cell-based liquid biopsy has been limited since CTCs are very rare, and current technologies cannot process the blood volumes required to isolate a sufficient number of tumor cells for in-depth assays. We previously described a high-throughput microfluidic prototype utilizing high-flow channels and amplification of cell sorting forces through magnetic lenses...
March 14, 2024: bioRxiv
https://read.qxmd.com/read/38549669/development-of-a-prognostic-model-based-on-different-disulfidptosis-related-genes-typing-for-kidney-renal-clear-cell-carcinoma
#17
JOURNAL ARTICLE
Yuanyuan Feng, Wenkai Wang, Shasha Jiang, Yongming Liu, Yan Wang, Xiangyang Zhan, Huirong Zhu, Guoqing Du
Background: Kidney renal clear cell carcinoma (KIRC) is a common and clinically significant subtype of kidney cancer. A potential therapeutic target in KIRC is disulfidptosis, a novel mode of cell death induced by disulfide stress. The aim of this study was to develop a prognostic model to explore the clinical significance of different disulfidptosis gene typings from KIRC. Methods: A comprehensive analysis of the chromosomal localization, expression patterns, mutational landscape, copy number variations, and prognostic significance of 10 disulfide death genes was conducted...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38545846/trauma-plays-an-important-role-in-acral-melanoma-a-retrospective-study-of-303-patients
#18
JOURNAL ARTICLE
Rong Huang, Mengke Zhao, Guiying Zhang, Yueling Yang, Jiayu Wang, Kelin Zheng, Lin Li, Xinyu Su, Lianjun Zhao, Yirong Wu, Zhengyun Zou
INTRODUCTION: Acral melanoma (AM) is the most common subtype of malignant melanoma in China, with a very poor prognosis. Despite the frequent reporting of trauma events in AM cases, the precise etiology of AM remains elusive. METHODS: A retrospective analysis was conducted on a cohort of 303 AM patients at Nanjing Drum Tower Hospital. The patients were categorized into four distinct groups based on different patterns of disease onset: trauma type (Type 1), pigmented nevus type (Type 2), pigmented nevi with trauma (Type 3), and pigmented nevi with natural ulceration (Type 4)...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38542469/use-of-enzymatically-converted-cell-free-dna-cfdna-data-for-copy-number-variation-linked-fragmentation-analysis-allows-for-early-colorectal-cancer-detection
#19
JOURNAL ARTICLE
Iva Černoša, Fernando Trincado-Alonso, Pol Canal-Noguer, Kristi Kruusmaa, Alexandre Perera-Lluna
The use of non-invasive liquid biopsy-based cell-free DNA (cfDNA) analysis is an emerging method of cancer detection and intervention. Different analytical methodologies are used to investigate cfDNA characteristics, resulting in costly and long analysis processes needed for combining different data. This study investigates the possibility of using cfDNA data converted for methylation analysis for combining the cfDNA fragment size with copy number variation (CNV) in the context of early colorectal cancer detection...
March 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38541033/integrating-optical-genome-mapping-and-whole-genome-sequencing-in-somatic-structural-variant-detection
#20
JOURNAL ARTICLE
Laura Budurlean, Diwakar Bastihalli Tukaramrao, Lijun Zhang, Sinisa Dovat, James Broach
Structural variants drive tumorigenesis by disrupting normal gene function through insertions, inversions, translocations, and copy number changes, including deletions and duplications. Detecting structural variants is crucial for revealing their roles in tumor development, clinical outcomes, and personalized therapy. Presently, most studies rely on short-read data from next-generation sequencing that aligns back to a reference genome to determine if and, if so, where a structural variant occurs. However, structural variant discovery by short-read sequencing is challenging, primarily because of the difficulty in mapping regions of repetitive sequences...
March 9, 2024: Journal of Personalized Medicine
keyword
keyword
67432
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.